164 related articles for article (PubMed ID: 38338476)
1. Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin.
Sun H; Nai J; Deng B; Zheng Z; Chen X; Zhang C; Sheng H; Zhu L
Molecules; 2024 Feb; 29(3):. PubMed ID: 38338476
[TBL] [Abstract][Full Text] [Related]
2. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer.
Zhang Y; Cui Z; Mei H; Xu J; Zhou T; Cheng F; Wang K
Carbohydr Polym; 2019 Sep; 219():143-154. PubMed ID: 31151511
[TBL] [Abstract][Full Text] [Related]
3. Self-assembled Angelica sinensis polysaccharide nanoparticles with an instinctive liver-targeting ability as a drug carrier for acute alcoholic liver damage protection.
Wang K; Xu J; Liu Y; Cui Z; He Z; Zheng Z; Huang X; Zhang Y
Int J Pharm; 2020 Mar; 577():118996. PubMed ID: 31904402
[TBL] [Abstract][Full Text] [Related]
4. RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin.
Xu J; Zhao JH; Liu Y; Feng NP; Zhang YT
Int J Nanomedicine; 2012; 7():211-9. PubMed ID: 22275836
[TBL] [Abstract][Full Text] [Related]
5. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
[TBL] [Abstract][Full Text] [Related]
6. Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin.
Duan C; Gao J; Zhang D; Jia L; Liu Y; Zheng D; Liu G; Tian X; Wang F; Zhang Q
Biomacromolecules; 2011 Dec; 12(12):4335-43. PubMed ID: 22077387
[TBL] [Abstract][Full Text] [Related]
7. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
8. Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice.
Lou H; Gao L; Wei X; Zhang Z; Zheng D; Zhang D; Zhang X; Li Y; Zhang Q
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):319-25. PubMed ID: 21676599
[TBL] [Abstract][Full Text] [Related]
9. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
[TBL] [Abstract][Full Text] [Related]
10. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
[TBL] [Abstract][Full Text] [Related]
12. Novel galactosylated biodegradable nanoparticles for hepatocyte-delivery of oridonin.
Wang Y; Liu X; Liu G; Guo H; Li C; Zhang Y; Zhang F; Zhao Z; Cheng H
Int J Pharm; 2016 Apr; 502(1-2):47-60. PubMed ID: 26911417
[TBL] [Abstract][Full Text] [Related]
13. The anti-tumor effect of folate-targeted liposome microbubbles loaded with oridonin as ultrasound-triggered tumor-targeted therapeutic carrier system.
Wang C; Li W; Hu B
J Drug Target; 2017 Jan; 25(1):83-91. PubMed ID: 27282800
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
[TBL] [Abstract][Full Text] [Related]
15. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
[TBL] [Abstract][Full Text] [Related]
17. Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer.
Qiu W; Chen R; Chen X; Zhang H; Song L; Cui W; Zhang J; Ye D; Zhang Y; Wang Z
Int J Nanomedicine; 2018; 13():6809-6827. PubMed ID: 30425490
[TBL] [Abstract][Full Text] [Related]
18. Angelica sinensis polysaccharides modified selenium nanoparticles for effective prevention of acute liver injury.
Xu Y; Wang XC; Jiang W; Hu JN
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130321. PubMed ID: 38382780
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab')
Jin C; Bai L; Lin L; Wang S; Yin X
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1076-1084. PubMed ID: 28776396
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
